|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270.37 USD | -0.68% |
|
+0.38% | -23.14% |
| Dec. 11 | Markets Wanted a Party. The Economy Brought a Reality Check. | |
| Dec. 11 | Accenture Invests in Healthcare Technology Firm Ryght AI to Accelerate Drug Development | MT |
| Fiscal Period: August | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.87 | 12.95 | 12.85 | 11.63 | 11.18 | |||||
Return on Total Capital | 21.37 | 23.57 | 22.73 | 19.81 | 18.41 | |||||
Return On Equity % | 31.87 | 32.62 | 28.47 | 26.67 | 25.51 | |||||
Return on Common Equity | 32.34 | 33.04 | 28.75 | 26.92 | 25.82 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 32.38 | 31.99 | 32.34 | 32.61 | 31.91 | |||||
SG&A Margin | 17.3 | 16.78 | 16.54 | 17.25 | 16.34 | |||||
EBITDA Margin % | 16.72 | 16.88 | 17.47 | 17.02 | 17.54 | |||||
EBITA Margin % | 15.7 | 15.92 | 16.48 | 16.18 | 16.65 | |||||
EBIT Margin % | 15.08 | 15.21 | 15.8 | 15.36 | 15.58 | |||||
Income From Continuing Operations Margin % | 11.85 | 11.35 | 10.92 | 11.43 | 11.24 | |||||
Net Income Margin % | 11.69 | 11.17 | 10.72 | 11.19 | 11.02 | |||||
Net Avail. For Common Margin % | 11.69 | 11.17 | 10.72 | 11.19 | 11.02 | |||||
Normalized Net Income Margin | 9.1 | 9.25 | 9.49 | 9.53 | 9.54 | |||||
Levered Free Cash Flow Margin | 14.67 | 12.55 | 13.87 | 11.75 | 15.04 | |||||
Unlevered Free Cash Flow Margin | 14.75 | 12.6 | 13.91 | 11.8 | 15.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.26 | 1.36 | 1.3 | 1.21 | 1.15 | |||||
Fixed Assets Turnover | 10.58 | 12.97 | 14.5 | 15.37 | 16.23 | |||||
Receivables Turnover (Average Receivables) | 5.75 | 5.73 | 5.34 | 5.01 | 4.86 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.25 | 1.23 | 1.3 | 1.1 | 1.42 | |||||
Quick Ratio | 1.14 | 1.12 | 1.18 | 0.98 | 1.3 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.54 | 0.53 | 0.48 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 63.47 | 63.72 | 68.33 | 73.01 | 75.04 | |||||
Average Days Payable Outstanding | 19.36 | 21.06 | 21.25 | 21.91 | 20.93 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 17.45 | 14.62 | 11.9 | 14.13 | 25.38 | |||||
Total Debt / Total Capital | 14.86 | 12.76 | 10.64 | 12.38 | 20.24 | |||||
LT Debt/Equity | 13.69 | 11.47 | 8.9 | 8.39 | 22.76 | |||||
Long-Term Debt / Total Capital | 11.65 | 10.01 | 7.95 | 7.35 | 18.16 | |||||
Total Liabilities / Total Assets | 53.45 | 51.87 | 48.37 | 47.85 | 50.7 | |||||
EBIT / Interest Expense | 128.11 | 197.95 | 213.08 | 169.06 | 47.49 | |||||
EBITDA / Interest Expense | 157.47 | 239.6 | 258.07 | 202.97 | 57.6 | |||||
(EBITDA - Capex) / Interest Expense | 147.72 | 224.43 | 246.95 | 194.21 | 54.98 | |||||
Total Debt / EBITDA | 0.37 | 0.29 | 0.26 | 0.34 | 0.62 | |||||
Net Debt / EBITDA | -0.5 | -0.4 | -0.48 | -0.07 | -0.25 | |||||
Total Debt / (EBITDA - Capex) | 0.4 | 0.31 | 0.27 | 0.36 | 0.65 | |||||
Net Debt / (EBITDA - Capex) | -0.53 | -0.43 | -0.5 | -0.08 | -0.26 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14 | 21.89 | 4.09 | 1.22 | 7.36 | |||||
Gross Profit, 1 Yr. Growth % | 17.09 | 20.39 | 5.23 | 2.08 | 5.07 | |||||
EBITDA, 1 Yr. Growth % | 16.77 | 23.11 | 0.73 | -1.26 | 10.64 | |||||
EBITA, 1 Yr. Growth % | 17.49 | 23.59 | 0.45 | -0.65 | 10.48 | |||||
EBIT, 1 Yr. Growth % | 17.01 | 22.9 | 0.45 | -1.55 | 8.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.53 | 16.67 | 0.21 | 5.94 | 5.57 | |||||
Net Income, 1 Yr. Growth % | 15.64 | 16.43 | -0.08 | 5.72 | 5.69 | |||||
Normalized Net Income, 1 Yr. Growth % | 16.42 | 23.89 | 6.86 | 1.56 | 7.57 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 15.96 | 16.98 | 0.58 | 6.16 | 6.27 | |||||
Accounts Receivable, 1 Yr. Growth % | 23.98 | 21.06 | 3.82 | 11.76 | 9.66 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.96 | -2.99 | -10.91 | 2.66 | 0.66 | |||||
Total Assets, 1 Yr. Growth % | 16.44 | 9.47 | 8.42 | 9.15 | 16.92 | |||||
Tangible Book Value, 1 Yr. Growth % | -9.55 | 6.77 | 12.78 | -47.01 | 46.52 | |||||
Common Equity, 1 Yr. Growth % | 14.88 | 13.19 | 16.23 | 10.1 | 10.28 | |||||
Cash From Operations, 1 Yr. Growth % | 9.25 | 6.31 | -0.18 | -4.13 | 25.66 | |||||
Capital Expenditures, 1 Yr. Growth % | -3.17 | 23.76 | -26.44 | -2.21 | 16.17 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 12.41 | 4.28 | 8.63 | -14.12 | 37.43 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 12.62 | 4.16 | 8.61 | -13.99 | 38.64 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.81 | 11.63 | 15.38 | 15.05 | 13.46 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.14 | 17.88 | 12.64 | 2.65 | 4.25 | |||||
Gross Profit, 2 Yr. CAGR % | 10.86 | 18.73 | 12.56 | 3.64 | 3.56 | |||||
EBITDA, 2 Yr. CAGR % | 10.48 | 14.1 | 10.24 | 3.08 | 5.73 | |||||
EBITA, 2 Yr. CAGR % | 10.63 | 20.5 | 15.41 | 3.47 | 6.05 | |||||
EBIT, 2 Yr. CAGR % | 9.95 | 19.92 | 15.27 | 3.16 | 4.85 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 11.18 | 16.1 | 8.12 | 3.03 | 5.75 | |||||
Net Income, 2 Yr. CAGR % | 11.17 | 16.03 | 7.86 | 2.78 | 5.71 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.42 | 17.06 | 13 | 4.18 | 3.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 11.53 | 16.47 | 8.47 | 3.33 | 6.22 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.62 | 22.51 | 12.11 | 7.72 | 10.7 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 86.17 | -0.54 | -7.03 | -4.36 | 1.66 | |||||
Total Assets, 2 Yr. CAGR % | 20.39 | 12.9 | 8.94 | 8.78 | 12.97 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.21 | -1.73 | 9.74 | -31.06 | -11.88 | |||||
Common Equity, 2 Yr. CAGR % | 16.42 | 14.03 | 14.7 | 13.12 | 10.19 | |||||
Cash From Operations, 2 Yr. CAGR % | 16.38 | 7.77 | 3.01 | -2.17 | 9.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | -1.59 | 9.47 | -4.58 | -15.18 | 6.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 16.93 | 2.57 | 4.24 | -0.68 | 9.62 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 17.07 | 2.62 | 4.18 | -0.63 | 10.18 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.19 | 12.22 | 13.49 | 15.22 | 14.25 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.22 | 12.54 | 13.09 | 8.7 | 4.19 | |||||
Gross Profit, 3 Yr. CAGR % | 9.41 | 13.95 | 14.05 | 8.95 | 4.12 | |||||
EBITDA, 3 Yr. CAGR % | 9.18 | 14.52 | 11.94 | 6.23 | 5.54 | |||||
EBITA, 3 Yr. CAGR % | 9.34 | 14.8 | 16.1 | 9.79 | 5.76 | |||||
EBIT, 3 Yr. CAGR % | 8.92 | 14.11 | 15.85 | 9.36 | 5.03 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 12.44 | 12.98 | 10.54 | 7.39 | 3.87 | |||||
Net Income, 3 Yr. CAGR % | 13.31 | 12.9 | 10.39 | 7.14 | 3.74 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.78 | 14.04 | 13.56 | 9.05 | 5.3 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.03 | 13.32 | 10.91 | 7.69 | 4.3 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.08 | 13.31 | 15.93 | 11.99 | 8.36 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 56.25 | 49.81 | -4.13 | -3.91 | -2.72 | |||||
Total Assets, 3 Yr. CAGR % | 20.87 | 16.63 | 11.39 | 9.01 | 11.43 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.04 | 3.03 | 2.89 | -20.24 | -11.36 | |||||
Common Equity, 3 Yr. CAGR % | 23.51 | 15.33 | 14.76 | 13.15 | 12.17 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.2 | 12.92 | 5.05 | 0.58 | 6.34 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.15 | 6.23 | -4.12 | -3.8 | -5.81 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 16.16 | 12.53 | 6.56 | -2.32 | 10.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.26 | 12.58 | 6.58 | -2.31 | 11.03 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.72 | 11.34 | 13.27 | 14.01 | 14.63 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.97 | 11.23 | 9.36 | 8.47 | 9.47 | |||||
Gross Profit, 5 Yr. CAGR % | 9.75 | 12.22 | 10.66 | 9.71 | 9.73 | |||||
EBITDA, 5 Yr. CAGR % | 9.96 | 12.95 | 11.52 | 9.8 | 8.88 | |||||
EBITA, 5 Yr. CAGR % | 9.99 | 13.13 | 11.73 | 10.13 | 11.43 | |||||
EBIT, 5 Yr. CAGR % | 9.64 | 12.74 | 11.41 | 9.6 | 10.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 6.61 | 13.97 | 10.69 | 8.89 | 8.6 | |||||
Net Income, 5 Yr. CAGR % | 7.51 | 14.83 | 11.1 | 8.74 | 8.49 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.03 | 13.08 | 11.86 | 9.99 | 9.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.25 | 14.5 | 11.18 | 9.21 | 9.01 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.35 | 11.33 | 10.28 | 11.04 | 13.81 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 38.2 | 32.61 | 26.95 | 25.19 | -1.85 | |||||
Total Assets, 5 Yr. CAGR % | 15.94 | 15.81 | 15.95 | 13.43 | 12.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.32 | 17.85 | 15.23 | -12.26 | -7.63 | |||||
Common Equity, 5 Yr. CAGR % | 20.92 | 19.82 | 19.91 | 14.44 | 12.91 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.97 | 13.92 | 9.58 | 6.62 | 6.91 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.16 | 6.83 | -3.13 | -2.92 | 0.03 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 15.27 | 12.28 | 13.45 | 7.05 | 7.36 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.32 | 12.31 | 13.46 | 7.1 | 7.59 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.41 | 10.74 | 11.82 | 12.87 | 13.66 |
- Stock Market
- Equities
- ACN Stock
- Financials Accenture plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















